Evidence map›Paper›PMID 34050441›Full record

ReviewClinical rheumatology2021

Rheumatology and psychiatry: allies in times of COVID-19.

Claudia Elera-Fitzcarrald, Jeff Huarcaya-Victoria, Graciela S Alarcón, Manuel F Ugarte-Gil

Open access · bronzeAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Clinical rheumatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Claudia Elera-FitzcarraldFacultad de Medicina, Universidad Científica del Sur, Av. Panamericana Sur km 19, Villa El Salvador, 15067, Lima, Peru. celerafi@cientifica.edu.pe.ORCID http://orcid.org/0000-0001-7271-2523
Jeff Huarcaya-VictoriaDepartamento Académico de Psiquiatría, Facultad de Medicina de San Fernando, Universidad Nacional Mayor de San Marcos, Lima, Peru.
Graciela S AlarcónFacultad de Medicina, Universidad Peruana Cayetano Heredia, Lima, Peru.
Manuel F Ugarte-GilFacultad de Medicina, Universidad Científica del Sur, Av. Panamericana Sur km 19, Villa El Salvador, 15067, Lima, Peru.
Universidad Científica del Sur · PENational University of San Marcos · PEUniversidad Peruana Cayetano Heredia · PE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 (coronavirus disease 2019) pandemic has had a significant global impact. Physical, emotional, and psychological health, particularly its specific mental health area, has been affected. Patients with rheumatic diseases are more likely to be concerned about COVID-19 than the public in general. Depression and anxiety are the symptoms most commonly reported by these patients. Therefore, now more than ever before, rheumatologists and psychiatrists should work together to improve the care of rheumatic disease patients, identifying the symptoms that uniquely reflect mental health problems, so the patients' quality of life can be substantially improved.

Indexed as

COVID-19PsychiatryRheumatologyAnxietyDepressionHumansQuality of LifeSARS-CoV-2Coronavirus disease 2019COVID-19Mental healthPsychiatristsRheumatic diseasesRheumatologists

Identifiers

PMID34050441
PMCPMC8162488
OpenAlexW3165874821

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.